Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials

Sahebkar, Amirhossein and Simental-Mendía, Luis E and Katsiki, Niki and Reiner, Željko and Banach, Maciej and Pirro, Matteo and Atkin, Stephen L (2019) Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials. BMJ Open, 8 (11). e021508. ISSN 2044-6055

[img] PDF - Published Version
Download (2MB)

Abstract

OBJECTIVES: This meta-analysis of randomised placebo-controlled clinical trials aimed to assess the effect of fenofibrate on apolipoprotein C-III (apo C-III), a key regulator of triglyceride metabolism. ----- MATERIALS AND METHODS: Randomised placebo-controlled trials investigating the impact of fenofibrate treatment on apo C-III levels were searched in PubMed-Medline, Scopus, Web of Science and Google Scholar databases from inception to 18 August 2017. Quantitative data synthesis was determined by a random-effects model and generic inverse variance method. Sensitivity analysis was conducted using the leave-one-out method. A weighted random-effects meta-regression was performed to evaluate glycaemic parameter confounders. ----- RESULTS: Meta-analysis of 10 clinical trials involving 477 subjects showed fenofibrate therapy decreased apo C-III levels (weighted mean difference (WMD) -4.78 mg/dL, 95% CI -6.95 to -2.61, p<0.001; I266.87%). Subgroup analysis showed that fenofibrate reduced plasma apo C-III concentrations in subgroups of trials with treatment durations of either <12 weeks (WMD -4.50 mg/dL, p=0.001) or ≥12 weeks (WMD: -4.73 mg/dL, p=0.009) and doses of fenofibrate <200 mg/day (WMD -6.33 mg/dL, p<0.001) and >200 mg/day (p=0.006), with no significant difference between the subgroups. ----- CONCLUSION: This meta-analysis found that fenofibrate therapy significantly decreases apo C-III levels, an effect evident with both short-term treatment and doses less than 200 mg/day.

Item Type: Article
Additional Information: © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Departments: Katedra za internu medicinu
Depositing User: Anja Majstorović
Status: Published
Creators:
CreatorsEmail
Sahebkar, AmirhosseinUNSPECIFIED
Simental-Mendía, Luis EUNSPECIFIED
Katsiki, NikiUNSPECIFIED
Reiner, ŽeljkoUNSPECIFIED
Banach, MaciejUNSPECIFIED
Pirro, MatteoUNSPECIFIED
Atkin, Stephen LUNSPECIFIED
Date: 22 February 2019
Date Deposited: 07 Jun 2019 10:32
Last Modified: 28 Aug 2020 07:40
Subjects: /
Related URLs:
URI: http://medlib.mef.hr/id/eprint/3259

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year